首页> 美国卫生研究院文献>Gut and Liver >Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives
【2h】

Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives

机译:间充质干细胞治疗肝病的研究现状与展望

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mesenchymal stem cell transplantation is an emerging therapy for treating chronic liver diseases. The potential of this treatment has been evaluated in preclinical and clinical studies. Although the mechanisms of mesenchymal stem cell transplantation are still not completely understood, accumulating evidence has revealed that their immunomodulation, differentiation, and antifibrotic properties play a crucial role in liver regeneration. The safety and therapeutic effects of mesenchymal stem cells in patients with chronic liver disease have been observed in many clinical studies. However, only modest improvements have been seen, partly because of the limited feasibility of transplanted cells at present. Here, we discuss several strategies targeted at improving viable cell engraftment and the potential challenges in the use of extracellular vesicle-based therapies for liver disease in the future.
机译:间充质干细胞移植是一种用于治疗慢性肝病的新兴疗法。在临床前和临床研究中已经评估了这种治疗的潜力。尽管间充质干细胞移植的机制仍不完全清楚,但越来越多的证据表明它们的免疫调节,分化和抗纤维化特性在肝再生中起着至关重要的作用。在许多临床研究中已观察到间充质干细胞在慢性肝病患者中的安全性和治疗作用。然而,仅看到了适度的改进,部分是由于目前移植细胞的可行性有限。在这里,我们讨论了针对改善活细胞移植的几种策略,以及在将来使用基于细胞外囊泡的疗法治疗肝脏疾病的潜在挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号